메뉴 건너뛰기




Volumn 35, Issue 4, 2011, Pages 315-320

Clostridium difficile infection in patients with ulcerative colitis: Investigations of risk factors and efficacy of antibiotics for steroid refractory patients

Author keywords

[No Author keywords available]

Indexed keywords

AZATHIOPRINE; CLOSTRIDIUM DIFFICILE TOXIN A; CORTICOSTEROID; CYCLOSPORIN A; MERCAPTOPURINE; MESALAZINE; METRONIDAZOLE; VANCOMYCIN;

EID: 79955021766     PISSN: 22107401     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.clinre.2011.02.004     Document Type: Article
Times cited : (30)

References (40)
  • 1
    • 33644523410 scopus 로고    scopus 로고
    • Clostridium difficile infection in patients discharged from US short-stay hospital, 1996-2003
    • McDonald L.C., Owings M., Jernigan D.B. Clostridium difficile infection in patients discharged from US short-stay hospital, 1996-2003. Emerg Infect Dis 2006, 12:409-415.
    • (2006) Emerg Infect Dis , vol.12 , pp. 409-415
    • McDonald, L.C.1    Owings, M.2    Jernigan, D.B.3
  • 2
    • 4444382260 scopus 로고    scopus 로고
    • Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity
    • Pepin J., Valiquette L., Alary M.E., Villemure P., Pelletier A., Forget K., et al. Clostridium difficile-associated diarrhea in a region of Quebec from 1991-2003: a changing pattern of disease severity. CMAJ 2004, 171:466-472.
    • (2004) CMAJ , vol.171 , pp. 466-472
    • Pepin, J.1    Valiquette, L.2    Alary, M.E.3    Villemure, P.4    Pelletier, A.5    Forget, K.6
  • 6
    • 0027535757 scopus 로고
    • Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile
    • Kochhar R., Ayyagari A., Goenka M.K., Dhali G.K., Aggarwal R., Mehta S.K. Role of infectious agents in exacerbations of ulcerative colitis in India. A study of Clostridium difficile. J Clin Gastroenterol 1993, 16:26-30.
    • (1993) J Clin Gastroenterol , vol.16 , pp. 26-30
    • Kochhar, R.1    Ayyagari, A.2    Goenka, M.K.3    Dhali, G.K.4    Aggarwal, R.5    Mehta, S.K.6
  • 7
    • 4644299551 scopus 로고    scopus 로고
    • The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease
    • Meyer A.M., Ramzan N.N., Loftus E.V., Heigh R.I., Leighton J.A. The diagnostic yield of stool pathogen studies during relapses of inflammatory bowel disease. J Clin Gastroenterol 2004, 38:772-775.
    • (2004) J Clin Gastroenterol , vol.38 , pp. 772-775
    • Meyer, A.M.1    Ramzan, N.N.2    Loftus, E.V.3    Heigh, R.I.4    Leighton, J.A.5
  • 8
    • 4043089351 scopus 로고    scopus 로고
    • Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool
    • Mylonaki M., Langmead L., Pantes A., Johnson F., Rampton D.S. Enteric infection in relapse of inflammatory bowel disease: importance of microbiological examination of stool. Eur J Gastroenterol Hepatol 2004, 16:775-778.
    • (2004) Eur J Gastroenterol Hepatol , vol.16 , pp. 775-778
    • Mylonaki, M.1    Langmead, L.2    Pantes, A.3    Johnson, F.4    Rampton, D.S.5
  • 10
    • 44949261865 scopus 로고    scopus 로고
    • A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients
    • Nguyen G.C., Kaplan G.G., Harris M.L., Brant S.R. A national survey of the prevalence and impact of Clostridium difficile infection among hospitalized inflammatory bowel disease patients. Am J Gastroenterol 2008, 103:1443-1450.
    • (2008) Am J Gastroenterol , vol.103 , pp. 1443-1450
    • Nguyen, G.C.1    Kaplan, G.G.2    Harris, M.L.3    Brant, S.R.4
  • 12
  • 13
    • 38549093523 scopus 로고    scopus 로고
    • Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease
    • Ananthakrishnan A.N., McGinley E.L., Binion D.G. Excess hospitalization burden associated with Clostridium difficile in patients with inflammatory bowel disease. Gut 2008, 57:205-210.
    • (2008) Gut , vol.57 , pp. 205-210
    • Ananthakrishnan, A.N.1    McGinley, E.L.2    Binion, D.G.3
  • 16
    • 58149193446 scopus 로고    scopus 로고
    • Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study
    • Matsumoto T., Andoh A., Okawa K., Ito H., Torii A., Yoshikawa S., et al. Multivariate analysis for factors predicting rapid response of leukocytapheresis in patients with steroid-resistant ulcerative colitis: a multicenter prospective open-label study. Ther Apher Dial 2008, 12:484-490.
    • (2008) Ther Apher Dial , vol.12 , pp. 484-490
    • Matsumoto, T.1    Andoh, A.2    Okawa, K.3    Ito, H.4    Torii, A.5    Yoshikawa, S.6
  • 17
    • 0008690916 scopus 로고
    • Cortisone in ulcerative colitis; final report on a therapeutic trial
    • Truelove S.C., Witts L.J. Cortisone in ulcerative colitis; final report on a therapeutic trial. Br Med J. 1955, 2:1041-1048.
    • (1955) Br Med J. , vol.2 , pp. 1041-1048
    • Truelove, S.C.1    Witts, L.J.2
  • 19
    • 0036111857 scopus 로고    scopus 로고
    • Role of infections in the manifestation or reactivation of inflammatory bowel disease
    • Stallmach A., Carstens O. Role of infections in the manifestation or reactivation of inflammatory bowel disease. Inflamm Bowel Dis 2002, 8:213-218.
    • (2002) Inflamm Bowel Dis , vol.8 , pp. 213-218
    • Stallmach, A.1    Carstens, O.2
  • 20
    • 38549098176 scopus 로고    scopus 로고
    • Prognosis in Clostridium difficile infection complicating inflammatory bowel disease
    • Stone C.D. Prognosis in Clostridium difficile infection complicating inflammatory bowel disease. Gut 2008, 57:150-152.
    • (2008) Gut , vol.57 , pp. 150-152
    • Stone, C.D.1
  • 21
    • 0025880322 scopus 로고
    • Clostridium difficile in inflammatory bowel disease relapse
    • Gryboski J.D. Clostridium difficile in inflammatory bowel disease relapse. J Pediatr Gastroenterol Nutr 1991, 13:39-41.
    • (1991) J Pediatr Gastroenterol Nutr , vol.13 , pp. 39-41
    • Gryboski, J.D.1
  • 22
    • 41149119335 scopus 로고    scopus 로고
    • Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis
    • Viget N., Vernier-Massouille G., Salmon-Ceron D., Yazdanpanah Y., Colombel J.F. Opportunistic infections in patients with inflammatory bowel disease: prevention and diagnosis. Gut 2008, 57:549-558.
    • (2008) Gut , vol.57 , pp. 549-558
    • Viget, N.1    Vernier-Massouille, G.2    Salmon-Ceron, D.3    Yazdanpanah, Y.4    Colombel, J.F.5
  • 24
    • 77149140102 scopus 로고    scopus 로고
    • Clostridium difficile infection and inflammatory bowel disease
    • Musa S., Thomson S., Cowan M., Rahman T. Clostridium difficile infection and inflammatory bowel disease. Scand J Gastroenterol 2010, 45:261-272.
    • (2010) Scand J Gastroenterol , vol.45 , pp. 261-272
    • Musa, S.1    Thomson, S.2    Cowan, M.3    Rahman, T.4
  • 25
    • 48249135038 scopus 로고    scopus 로고
    • Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent?
    • Powell N., Jung S.E., Krishnan B. Clostridium difficile infection and inflammatory bowel disease: a marker for disease extent?. Gut 2008, 57:1183-1184.
    • (2008) Gut , vol.57 , pp. 1183-1184
    • Powell, N.1    Jung, S.E.2    Krishnan, B.3
  • 26
    • 69249181666 scopus 로고    scopus 로고
    • Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection
    • Ben-Horin S., Margalit M., Bossuyt P., Maul J., Shapira Y., Bojic D., et al. Combination immunomodulator and antibiotic treatment in patients with inflammatory bowel disease and Clostridium difficile infection. Clin Gastroenterol Hepatol 2009, 7:981-987.
    • (2009) Clin Gastroenterol Hepatol , vol.7 , pp. 981-987
    • Ben-Horin, S.1    Margalit, M.2    Bossuyt, P.3    Maul, J.4    Shapira, Y.5    Bojic, D.6
  • 27
    • 67650430007 scopus 로고    scopus 로고
    • Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections
    • Schneeweiss S., Korzenik J., Solomon D.H., Canning C., Lee J., Bressler B. Infliximab and other immunomodulating drugs in patients with inflammatory bowel disease and the risk of serious bacterial infections. Aliment Pharmacol Ther 2009, 30:253-264.
    • (2009) Aliment Pharmacol Ther , vol.30 , pp. 253-264
    • Schneeweiss, S.1    Korzenik, J.2    Solomon, D.H.3    Canning, C.4    Lee, J.5    Bressler, B.6
  • 28
    • 0037204196 scopus 로고    scopus 로고
    • Antibiotic-associated diarrhea
    • Bartlett J.G., Clinical practice. Antibiotic-associated diarrhea. N Engl J Med 2002, 346:334-339.
    • (2002) N Engl J Med , vol.346 , pp. 334-339
    • Bartlett, J.G.1    Clinical, P.2
  • 29
    • 0035436311 scopus 로고    scopus 로고
    • Epidemiology of Clostridium difficile-associated infection
    • Barbut F., Petit J.C. Epidemiology of Clostridium difficile-associated infection. Clin Microbiol Infect 2001, 7:405-410.
    • (2001) Clin Microbiol Infect , vol.7 , pp. 405-410
    • Barbut, F.1    Petit, J.C.2
  • 30
    • 34848836638 scopus 로고    scopus 로고
    • Increase in Clostridium difficile-related mortality rates, United States, 1999-2004
    • Redelings M.D., Sorvillo F., Mascola L. Increase in Clostridium difficile-related mortality rates, United States, 1999-2004. Emerg Infect Dis 2007, 13:1417-1419.
    • (2007) Emerg Infect Dis , vol.13 , pp. 1417-1419
    • Redelings, M.D.1    Sorvillo, F.2    Mascola, L.3
  • 31
    • 0031752883 scopus 로고    scopus 로고
    • Risk factors for Clostridium difficile infection
    • Bignardi G.E. Risk factors for Clostridium difficile infection. J Hosp Infect 1998, 40:1-15.
    • (1998) J Hosp Infect , vol.40 , pp. 1-15
    • Bignardi, G.E.1
  • 32
    • 58849083648 scopus 로고    scopus 로고
    • Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease
    • Bossuyt P., Verhaegen J., Van Assche G., Rutgeerts P., Vermeire S. Increasing incidence of Clostridium difficile-associated diarrhea in inflammatory bowel disease. J Crohn's Colitis 2009, 3:4-7.
    • (2009) J Crohn's Colitis , vol.3 , pp. 4-7
    • Bossuyt, P.1    Verhaegen, J.2    Van Assche, G.3    Rutgeerts, P.4    Vermeire, S.5
  • 33
    • 3142705643 scopus 로고    scopus 로고
    • Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies
    • Dial S., Alrasadi K., Manoukian C., Huang A., Menzies D. Risk of Clostridium difficile diarrhea among hospital inpatients prescribed proton pump inhibitors: cohort and case-control studies. CMAJ 2004, 171:33-38.
    • (2004) CMAJ , vol.171 , pp. 33-38
    • Dial, S.1    Alrasadi, K.2    Manoukian, C.3    Huang, A.4    Menzies, D.5
  • 34
    • 29144473282 scopus 로고    scopus 로고
    • Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease
    • Dial S., Delaney J.A., Barkun A.N., Suissa S. Use of gastric acid-suppressive agents and the risk of community-acquired Clostridium difficile-associated disease. JAMA 2005, 294:2989-2995.
    • (2005) JAMA , vol.294 , pp. 2989-2995
    • Dial, S.1    Delaney, J.A.2    Barkun, A.N.3    Suissa, S.4
  • 35
    • 34547814762 scopus 로고    scopus 로고
    • Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools
    • Hauben M., Horn S., Reich L., Younus M. Association between gastric acid suppressants and Clostridium difficile colitis and community-acquired pneumonia: analysis using pharmacovigilance tools. Int J Infect Dis 2007, 11:417-422.
    • (2007) Int J Infect Dis , vol.11 , pp. 417-422
    • Hauben, M.1    Horn, S.2    Reich, L.3    Younus, M.4
  • 36
    • 50649112615 scopus 로고    scopus 로고
    • Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients
    • Aseeri M., Schroeder T., Kramer J., Zackula R. Gastric acid suppression by proton pump inhibitors as a risk factor for Clostridium difficile-associated diarrhea in hospitalized patients. Am J Gastroenterol 2008, 103:2308-2313.
    • (2008) Am J Gastroenterol , vol.103 , pp. 2308-2313
    • Aseeri, M.1    Schroeder, T.2    Kramer, J.3    Zackula, R.4
  • 37
    • 76849114352 scopus 로고    scopus 로고
    • Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection
    • Jodorkovsky D., Young Y., Abreu M.T. Clinical outcomes of patients with ulcerative colitis and co-existing Clostridium difficile infection. Dig Dis Sci 2010, 55:415-420.
    • (2010) Dig Dis Sci , vol.55 , pp. 415-420
    • Jodorkovsky, D.1    Young, Y.2    Abreu, M.T.3
  • 38
    • 38749106156 scopus 로고    scopus 로고
    • European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis
    • Stange E.F., Travis S.P., Vermeire S., Reinisch W., Geboes K., Barakauskiene A., et al. European evidence-based consensus on the diagnosis and management of ulcerative colitis: definitions and diagnosis. J Crohn's Colitis 2008, 2:1-23.
    • (2008) J Crohn's Colitis , vol.2 , pp. 1-23
    • Stange, E.F.1    Travis, S.P.2    Vermeire, S.3    Reinisch, W.4    Geboes, K.5    Barakauskiene, A.6
  • 39
    • 66949151443 scopus 로고    scopus 로고
    • The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission
    • Clayton E.M., Rea M.C., Shanahan F., Quigley E.M., Kiely B., Hill C., et al. The vexed relationship between Clostridium difficile and inflammatory bowel disease: an assessment of carriage in an outpatient setting among patients in remission. Am J Gastroenterol 2009, 104:1162-1169.
    • (2009) Am J Gastroenterol , vol.104 , pp. 1162-1169
    • Clayton, E.M.1    Rea, M.C.2    Shanahan, F.3    Quigley, E.M.4    Kiely, B.5    Hill, C.6
  • 40
    • 0020069201 scopus 로고
    • Isolation of Clostridium difficile from patients with inactive Crohn's disease
    • Dorman S.A., Liggoria E., Winn W.C., Beeken W.L. Isolation of Clostridium difficile from patients with inactive Crohn's disease. Gastroenterology 1982, 82:1348-1351.
    • (1982) Gastroenterology , vol.82 , pp. 1348-1351
    • Dorman, S.A.1    Liggoria, E.2    Winn, W.C.3    Beeken, W.L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.